Risk factors associated with metabolic syndrome increased natriuresis

被引：0

作者：

Hernandez, Jesus D. ^{[1
,2
]}

Alfieri, Anna B. ^{[1
]}

Hoffmann, Irene S. ^{[1
]}

Ramirez, Alcira ^{[3
]}

机构：

[1] Univ Cent Venezuela, Fac Farm, Unidad Farmacol Clin, Caracas, Venezuela

[2] Univ Cent Venezuela, Fac Odontol, Catedra Bioquim, Caracas, Venezuela

[3] Hosp Univ Caracas, Caracas, Venezuela

来源：

REVISTA LATINOAMERICANA DE HIPERTENSION | 2012年 / 7卷 / 03期

关键词：

Metabolic Syndrome; Urinary sodium; Risk Factor;

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Objective: To establish whether an association exist between each component of Metabolic Syndrome (MS) and increased natriuresis. Methodology: We analyzed 998 subjects of 48, 8 +/- 0.35 years of age and measured: Body Mass Index (BMI), Waist Circumference (WC), Systolic Blood pressure (SBP), Diastolic (DBP), glycemia, lipid profile and urinary electrolyte excretion in 24 hours. Results: The high WC was the most frequent parameter (61,6%), natriuresis was higher in subjects with MS compared to those without SM (173 +/- 4.9 vs. 157 +/- 2.7 mEq/24 hours) (p < 0.0032), and only significantly correlated with BMI, WC, SBP and DBP (r = 0.394, 0.293, 0.183 and 0.214 respectively, p < 0.0001). Conclusion: increased natriuresis in MS subjets, seems to depend on adiposity, but not related to changes in glycemia or lipemia.

引用

页码：53 / 57

页数：5

共 23 条

[1] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
Alberti, KGMM
Zimmet, P
Shaw, J
[J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480
[2] Baculikova M, 2008, GEN PHYSIOL BIOPHYS, V27, P222
[3] PORTAL ADIPOSE-TISSUE AS A GENERATOR OF RISK-FACTORS FOR CARDIOVASCULAR-DISEASE AND DIABETES
BJORNTORP, P
[J]. ARTERIOSCLEROSIS, 1990, 10 (04): : 493 - 496
[4] Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited
Ceriello, A
Motz, E
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : 816 - 823
[5] Effects of oral monosodium (L)-glutamate on insulin secretion and glucose tolerance in healthy volunteers
Chevassus, H
Renard, E
Bertrand, G
Mourand, I
Puech, R
Molinier, N
Bockaert, J
Petit, P
Bringer, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (06) : 641 - 643
[6] Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)
Cook, Nancy R.
Cutler, Jeffrey A.
Obarzanek, Eva
Buring, Julie E.
Rexrode, Kathryn M.
Kumanyika, Shiriki K.
Appel, Lawrence J.
Whelton, Paul K.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7599): : 885 - 888B
[7] Enas Enas A, 2007, J Cardiometab Syndr, V2, P267, DOI 10.1111/j.1559-4564.2007.07392.x
[8] Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study
Escobedo, Jorge
Schargrodsky, Herman
Champagne, Beatriz
Silva, Honorio
Boissonnet, Carlos P.
Vinueza, Raul
Torres, Marta
Hernandez, Rafael
Wilson, Elinor
[J]. CARDIOVASCULAR DIABETOLOGY, 2009, 8 : 52
[9] Effects of lifestyle changes and metformin on salt sensitivity and nitric oxide metabolism in obese salt-sensitive Hispanics
Hoffmann, I. S.
Alfieri, A. B.
Cubeddu, L. X.
[J]. JOURNAL OF HUMAN HYPERTENSION, 2007, 21 (07) : 571 - 578
[10] Salt and the metabolic syndrome
Hoffmann, Irene S.
Cubeddu, Luigi X.
[J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (02) : 123 - 128

← 1 2 3 →